The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model

Neutrophil infiltration, proinflammatory cytokines, eicosanoid generation and oxidative stress have been implicated in colitis. Resveratrol is a polyphenolic compound found in grapes and wine, with multiple pharmacological actions, including anti‐inflammatory, antioxidant, antitumour and immunomodul...

Full description

Saved in:
Bibliographic Details
Published in:British journal of pharmacology Vol. 147; no. 8; pp. 873 - 885
Main Authors: Martín, Antonio Ramón, Villegas, Isabel, Sánchez‐Hidalgo, Marina, De La Lastra, Catalina Alarcón
Format: Journal Article
Language:English
Published: Oxford, UK Blackwell Publishing Ltd 01-04-2006
Nature Publishing
Nature Publishing Group
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Neutrophil infiltration, proinflammatory cytokines, eicosanoid generation and oxidative stress have been implicated in colitis. Resveratrol is a polyphenolic compound found in grapes and wine, with multiple pharmacological actions, including anti‐inflammatory, antioxidant, antitumour and immunomodulatory activities. In a previous report, we documented that resveratrol decreases the degree of inflammation associated with acute experimental colonic inflammation, but its effects on chronic experimental colitis remain undetermined. The aim of this research was to investigate the effects of resveratrol on the chronic colonic injury caused by intracolonic instillation of trinitrobenzenesulphonic acid (TNBS) in rats. The inflammatory response was assessed by histology and myeloperoxidase activity. Tumour necrosis factor alpha (TNF‐α) production, histological and histochemical analysis of the lesions were also carried out. We determined the production of prostaglandin (PG) E2 and D2 in colon mucosa, as well as cyclooxygenase (COX)‐1 and ‐2 and nuclear transcription factor NF‐kappa B (NF‐κB) p65 protein expression. Finally, since resveratrol has been found to modulate apoptosis, we intended to elucidate its effects on colonic mucosa under chronic inflammatory conditions. Resveratrol (10 mg kg−1 day−1) significantly attenuated the damage score and corrected the disturbances in morphology associated to injury. In addition, the degree of neutrophil infiltration and the levels of TNF‐α were significantly ameliorated. Resveratrol did not modify PGD2 levels but returned the decreased PGE2 values to basal levels and also reduced COX‐2 and the NF‐κB p65 protein expression. Furthermore, treatment of rats with resveratrol caused a significant increase of TNBS‐induced apoptosis in colonic cells. In conclusion, resveratrol reduces the damage in chronic experimentally induced colitis, alleviates the oxidative events, returns PGE2 production to basal levels and stimulates apoptosis in colonic cells. British Journal of Pharmacology (2006) 147, 873–885. doi:10.1038/sj.bjp.0706469
AbstractList Neutrophil infiltration, proinflammatory cytokines, eicosanoid generation and oxidative stress have been implicated in colitis. Resveratrol is a polyphenolic compound found in grapes and wine, with multiple pharmacological actions, including anti-inflammatory, antioxidant, antitumour and immunomodulatory activities. In a previous report, we documented that resveratrol decreases the degree of inflammation associated with acute experimental colonic inflammation, but its effects on chronic experimental colitis remain undetermined. The aim of this research was to investigate the effects of resveratrol on the chronic colonic injury caused by intracolonic instillation of trinitrobenzenesulphonic acid (TNBS) in rats. The inflammatory response was assessed by histology and myeloperoxidase activity. Tumour necrosis factor alpha (TNF-alpha) production, histological and histochemical analysis of the lesions were also carried out. We determined the production of prostaglandin (PG) E2 and D2 in colon mucosa, as well as cyclooxygenase (COX)-1 and -2 and nuclear transcription factor NF-kappa B (NF-kappaB) p65 protein expression. Finally, since resveratrol has been found to modulate apoptosis, we intended to elucidate its effects on colonic mucosa under chronic inflammatory conditions. Resveratrol (10 mg kg(-1) day(-1)) significantly attenuated the damage score and corrected the disturbances in morphology associated to injury. In addition, the degree of neutrophil infiltration and the levels of TNF-alpha were significantly ameliorated. Resveratrol did not modify PGD2 levels but returned the decreased PGE2 values to basal levels and also reduced COX-2 and the NF-kappaB p65 protein expression. Furthermore, treatment of rats with resveratrol caused a significant increase of TNBS-induced apoptosis in colonic cells. In conclusion, resveratrol reduces the damage in chronic experimentally induced colitis, alleviates the oxidative events, returns PGE2 production to basal levels and stimulates apoptosis in colonic cells.
Neutrophil infiltration, proinflammatory cytokines, eicosanoid generation and oxidative stress have been implicated in colitis. Resveratrol is a polyphenolic compound found in grapes and wine, with multiple pharmacological actions, including anti‐inflammatory, antioxidant, antitumour and immunomodulatory activities. In a previous report, we documented that resveratrol decreases the degree of inflammation associated with acute experimental colonic inflammation, but its effects on chronic experimental colitis remain undetermined. The aim of this research was to investigate the effects of resveratrol on the chronic colonic injury caused by intracolonic instillation of trinitrobenzenesulphonic acid (TNBS) in rats. The inflammatory response was assessed by histology and myeloperoxidase activity. Tumour necrosis factor alpha (TNF‐ α ) production, histological and histochemical analysis of the lesions were also carried out. We determined the production of prostaglandin (PG) E 2 and D 2 in colon mucosa, as well as cyclooxygenase (COX)‐1 and ‐2 and nuclear transcription factor NF‐kappa B (NF‐ κ B) p65 protein expression. Finally, since resveratrol has been found to modulate apoptosis, we intended to elucidate its effects on colonic mucosa under chronic inflammatory conditions. Resveratrol (10 mg kg −1  day −1 ) significantly attenuated the damage score and corrected the disturbances in morphology associated to injury. In addition, the degree of neutrophil infiltration and the levels of TNF‐ α were significantly ameliorated. Resveratrol did not modify PGD 2 levels but returned the decreased PGE 2 values to basal levels and also reduced COX‐2 and the NF‐ κ B p65 protein expression. Furthermore, treatment of rats with resveratrol caused a significant increase of TNBS‐induced apoptosis in colonic cells. In conclusion, resveratrol reduces the damage in chronic experimentally induced colitis, alleviates the oxidative events, returns PGE 2 production to basal levels and stimulates apoptosis in colonic cells. British Journal of Pharmacology (2006) 147 , 873–885. doi: 10.1038/sj.bjp.0706469
Neutrophil infiltration, proinflammatory cytokines, eicosanoid generation and oxidative stress have been implicated in colitis. Resveratrol is a polyphenolic compound found in grapes and wine, with multiple pharmacological actions, including anti-inflammatory, antioxidant, antitumour and immunomodulatory activities. In a previous report, we documented that resveratrol decreases the degree of inflammation associated with acute experimental colonic inflammation, but its effects on chronic experimental colitis remain undetermined. The aim of this research was to investigate the effects of resveratrol on the chronic colonic injury caused by intracolonic instillation of trinitrobenzenesulphonic acid (TNBS) in rats. The inflammatory response was assessed by histology and myeloperoxidase activity. Tumour necrosis factor alpha (TNF- α ) production, histological and histochemical analysis of the lesions were also carried out. We determined the production of prostaglandin (PG) E 2 and D 2 in colon mucosa, as well as cyclooxygenase (COX)-1 and -2 and nuclear transcription factor NF-kappa B (NF- κ B) p65 protein expression. Finally, since resveratrol has been found to modulate apoptosis, we intended to elucidate its effects on colonic mucosa under chronic inflammatory conditions. Resveratrol (10 mg kg −1  day −1 ) significantly attenuated the damage score and corrected the disturbances in morphology associated to injury. In addition, the degree of neutrophil infiltration and the levels of TNF- α were significantly ameliorated. Resveratrol did not modify PGD 2 levels but returned the decreased PGE 2 values to basal levels and also reduced COX-2 and the NF- κ B p65 protein expression. Furthermore, treatment of rats with resveratrol caused a significant increase of TNBS-induced apoptosis in colonic cells. In conclusion, resveratrol reduces the damage in chronic experimentally induced colitis, alleviates the oxidative events, returns PGE 2 production to basal levels and stimulates apoptosis in colonic cells.
Neutrophil infiltration, proinflammatory cytokines, eicosanoid generation and oxidative stress have been implicated in colitis. Resveratrol is a polyphenolic compound found in grapes and wine, with multiple pharmacological actions, including anti‐inflammatory, antioxidant, antitumour and immunomodulatory activities. In a previous report, we documented that resveratrol decreases the degree of inflammation associated with acute experimental colonic inflammation, but its effects on chronic experimental colitis remain undetermined. The aim of this research was to investigate the effects of resveratrol on the chronic colonic injury caused by intracolonic instillation of trinitrobenzenesulphonic acid (TNBS) in rats. The inflammatory response was assessed by histology and myeloperoxidase activity. Tumour necrosis factor alpha (TNF‐α) production, histological and histochemical analysis of the lesions were also carried out. We determined the production of prostaglandin (PG) E2 and D2 in colon mucosa, as well as cyclooxygenase (COX)‐1 and ‐2 and nuclear transcription factor NF‐kappa B (NF‐κB) p65 protein expression. Finally, since resveratrol has been found to modulate apoptosis, we intended to elucidate its effects on colonic mucosa under chronic inflammatory conditions. Resveratrol (10 mg kg−1 day−1) significantly attenuated the damage score and corrected the disturbances in morphology associated to injury. In addition, the degree of neutrophil infiltration and the levels of TNF‐α were significantly ameliorated. Resveratrol did not modify PGD2 levels but returned the decreased PGE2 values to basal levels and also reduced COX‐2 and the NF‐κB p65 protein expression. Furthermore, treatment of rats with resveratrol caused a significant increase of TNBS‐induced apoptosis in colonic cells. In conclusion, resveratrol reduces the damage in chronic experimentally induced colitis, alleviates the oxidative events, returns PGE2 production to basal levels and stimulates apoptosis in colonic cells. British Journal of Pharmacology (2006) 147, 873–885. doi:10.1038/sj.bjp.0706469
Author Martín, Antonio Ramón
Villegas, Isabel
Sánchez‐Hidalgo, Marina
De La Lastra, Catalina Alarcón
AuthorAffiliation 1 Department of Pharmacology, Faculty of Pharmacy, University of Seville, Profesor García González Street 2, Sevilla 41012, Spain
AuthorAffiliation_xml – name: 1 Department of Pharmacology, Faculty of Pharmacy, University of Seville, Profesor García González Street 2, Sevilla 41012, Spain
Author_xml – sequence: 1
  givenname: Antonio Ramón
  surname: Martín
  fullname: Martín, Antonio Ramón
– sequence: 2
  givenname: Isabel
  surname: Villegas
  fullname: Villegas, Isabel
– sequence: 3
  givenname: Marina
  surname: Sánchez‐Hidalgo
  fullname: Sánchez‐Hidalgo, Marina
– sequence: 4
  givenname: Catalina Alarcón
  surname: De La Lastra
  fullname: De La Lastra, Catalina Alarcón
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17731715$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/16474422$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1uEzEUhS1URNPCliWykNg1wZ7xjD0bJKgKRaoEi7K2_HNNHHnsYE_S5h146Bpl1MKKlSWf795zdM8ZOokpAkKvKVlR0or3ZbPSm-2KcNKzfniGFpTxftm1gp6gBSGELykV4hSdlbIhpIq8e4FOac84Y02zQL9v14DBOTBTwcnhDGUPWU05hQus8HZ9mJIKcO8jtpD9Hix2OY2Vs_jORygXOEVs1jlFb7CPLqhxVJOvnz7analYHVURw_22zo8QJxXC4VE0KfjJFzwmC-Eleu5UKPBqfs_Rj89Xt5fXy5tvX75efrxZmq7rhqXmrGdOaN1C04C2zoiOQ08aZq222nUdH3qhG80apzgXnPd2oEy0zHZcU9Oeow_HvdudHsGaGiqrILc1n8oHmZSX_yrRr-XPtJeU9_XSvC54Oy_I6dcOyiQ3aZdjzSwbyunABREVWh0hk1MpGdyjASXyT3mybGQtT87l1YE3f8d6wue2KvBuBlQxKrisovHlieO8re5d5dojd-cDHP5jKz99v276dmgfALNcuRY
CODEN BJPCBM
CitedBy_id crossref_primary_10_1016_j_enzmictec_2010_09_004
crossref_primary_10_3390_antiox9010035
crossref_primary_10_1002_mnfr_200800148
crossref_primary_10_1021_jf071741n
crossref_primary_10_1186_1476_511X_7_14
crossref_primary_10_1158_1940_6207_CAPR_09_0117
crossref_primary_10_1021_jf803638d
crossref_primary_10_3390_jfb6010033
crossref_primary_10_3390_antiox9080669
crossref_primary_10_1124_jpet_109_160838
crossref_primary_10_1111_j_1476_5381_2010_00785_x
crossref_primary_10_1016_j_bcp_2011_06_043
crossref_primary_10_1186_1742_2094_6_26
crossref_primary_10_1016_j_bbapap_2009_09_015
crossref_primary_10_1016_j_biopha_2019_01_001
crossref_primary_10_1017_S0007114511007227
crossref_primary_10_3748_wjg_v21_i21_6572
crossref_primary_10_3109_02652048_2011_559284
crossref_primary_10_34172_apb_2020_023
crossref_primary_10_1016_j_nlm_2010_08_009
crossref_primary_10_1016_j_taap_2020_114919
crossref_primary_10_1016_j_yexcr_2019_06_024
crossref_primary_10_1053_j_gastro_2013_07_015
crossref_primary_10_1177_0960327110383638
crossref_primary_10_1016_j_ejmech_2019_111805
crossref_primary_10_1038_bjp_2008_330
crossref_primary_10_1016_j_intimp_2006_11_006
crossref_primary_10_1080_02713683_2020_1803920
crossref_primary_10_1371_journal_pone_0109048
crossref_primary_10_1016_j_jnutbio_2012_11_009
crossref_primary_10_1007_s00204_008_0309_7
crossref_primary_10_1111_j_1753_4887_2009_00210_x
crossref_primary_10_1111_bph_15895
crossref_primary_10_1248_bpb_b19_00786
crossref_primary_10_3389_fncel_2019_00030
crossref_primary_10_1007_s00417_014_2604_8
crossref_primary_10_1155_2020_4253174
crossref_primary_10_1016_j_ijpharm_2019_118713
crossref_primary_10_1177_011542650802300149
crossref_primary_10_1111_j_1476_5381_2009_00572_x
crossref_primary_10_1208_s12249_010_9435_7
crossref_primary_10_1053_j_gastro_2020_05_011
crossref_primary_10_13005_bpj_2831
crossref_primary_10_1016_j_ejphar_2010_01_025
crossref_primary_10_1016_j_intimp_2016_03_004
crossref_primary_10_3109_1061186X_2010_504272
crossref_primary_10_1089_jmf_2013_2976
crossref_primary_10_1155_2012_751629
crossref_primary_10_1007_s11101_012_9265_1
crossref_primary_10_1371_journal_pone_0139147
crossref_primary_10_3389_fimmu_2022_855342
crossref_primary_10_1016_j_peptides_2008_07_013
crossref_primary_10_1016_j_taap_2013_01_009
crossref_primary_10_1016_j_ijpharm_2009_10_016
crossref_primary_10_1016_j_jep_2011_08_019
crossref_primary_10_3390_antiox9080725
crossref_primary_10_1016_j_foodhyd_2020_106291
crossref_primary_10_3390_nu11051000
crossref_primary_10_1165_rcmb_2016_0192OC
crossref_primary_10_1111_j_1745_7254_2007_00694_x
crossref_primary_10_3390_ijms23020920
crossref_primary_10_1016_j_phrs_2017_08_002
crossref_primary_10_1042_BST0351156
crossref_primary_10_1016_j_ejphar_2013_08_040
crossref_primary_10_1016_j_ijfoodmicro_2010_04_007
crossref_primary_10_1111_j_1745_7254_2007_00690_x
crossref_primary_10_3390_ijms15022368
crossref_primary_10_1007_s00213_015_4188_3
crossref_primary_10_1002_jps_22212
crossref_primary_10_1097_MCO_0b013e3282f0cef2
crossref_primary_10_3390_molecules21010033
crossref_primary_10_1080_08941930903214701
crossref_primary_10_1002_biof_1298
crossref_primary_10_1016_j_bbadis_2014_12_024
crossref_primary_10_1016_j_tox_2007_04_012
crossref_primary_10_1016_j_jff_2015_05_046
crossref_primary_10_1016_j_pharmthera_2018_06_013
crossref_primary_10_1021_jm1007006
crossref_primary_10_3390_molecules25225453
crossref_primary_10_1189_jlb_1112557
crossref_primary_10_1016_j_ejphar_2007_01_047
crossref_primary_10_1016_j_taap_2007_03_025
crossref_primary_10_3389_fnut_2017_00059
crossref_primary_10_1007_s11101_013_9320_6
crossref_primary_10_1016_j_ejphar_2008_10_005
crossref_primary_10_1016_j_bbrc_2015_01_034
crossref_primary_10_1515_bc_2010_100
crossref_primary_10_1093_toxsci_kfq360
crossref_primary_10_1016_j_jnutbio_2015_12_002
crossref_primary_10_1016_j_nutres_2016_11_003
crossref_primary_10_1177_014556130808701010
crossref_primary_10_1016_j_cbi_2015_06_026
crossref_primary_10_1371_journal_pone_0024740
crossref_primary_10_1007_s12602_011_9081_8
crossref_primary_10_1016_j_ijpharm_2010_12_015
crossref_primary_10_1016_j_lfs_2023_121915
crossref_primary_10_1016_j_intimp_2015_04_026
crossref_primary_10_1080_10408390903584094
crossref_primary_10_1016_j_ejphar_2009_03_062
crossref_primary_10_1016_j_fct_2014_04_032
crossref_primary_10_1016_j_jnutbio_2011_06_003
crossref_primary_10_1017_S095442241700021X
crossref_primary_10_1007_s11064_014_1340_0
crossref_primary_10_1152_ajpgi_00083_2011
crossref_primary_10_1007_s00394_011_0235_y
crossref_primary_10_1021_acs_molpharmaceut_0c00048
crossref_primary_10_3748_wjg_v24_i25_2673
crossref_primary_10_1016_j_regpep_2006_12_029
crossref_primary_10_1016_j_phrs_2012_05_006
crossref_primary_10_1038_bjp_2008_137
crossref_primary_10_1038_mi_2014_35
crossref_primary_10_1080_1028415X_2019_1596613
crossref_primary_10_1007_s10620_011_1821_9
crossref_primary_10_1177_1753465807086096
crossref_primary_10_1016_j_etap_2014_02_006
crossref_primary_10_1155_2017_8051870
crossref_primary_10_1017_S000711451300007X
crossref_primary_10_1007_s11033_020_05753_4
crossref_primary_10_1177_0884533611423927
crossref_primary_10_1016_j_tiv_2012_06_015
crossref_primary_10_1016_j_fct_2007_09_002
crossref_primary_10_1080_10408398_2019_1570913
crossref_primary_10_1016_j_intimp_2008_08_003
crossref_primary_10_1080_10584587_2021_1911228
crossref_primary_10_1016_j_tifs_2021_05_001
crossref_primary_10_1016_j_freeradbiomed_2019_09_021
crossref_primary_10_1155_2012_805762
crossref_primary_10_3390_ijms19020426
crossref_primary_10_31612_2616_4868_8_2023_11
crossref_primary_10_1016_j_ejphar_2011_08_036
crossref_primary_10_1016_j_fct_2019_02_044
crossref_primary_10_1016_j_ntt_2020_106905
crossref_primary_10_1016_j_carbpol_2014_09_012
crossref_primary_10_1016_j_jep_2010_01_024
crossref_primary_10_1111_jpn_12536
crossref_primary_10_1586_17474124_2_2_261
crossref_primary_10_3390_molecules26195891
crossref_primary_10_3390_ijms20174321
crossref_primary_10_1016_j_ejphar_2007_01_070
crossref_primary_10_1080_10284150600841547
crossref_primary_10_1002_JLB_3A1218_476RR
crossref_primary_10_2174_2589977515666230502153206
crossref_primary_10_1016_j_bbi_2011_07_236
crossref_primary_10_3390_molecules191117578
crossref_primary_10_3390_metabo13010096
crossref_primary_10_1016_j_freeradbiomed_2018_07_002
crossref_primary_10_1016_j_arcmed_2015_05_005
crossref_primary_10_1007_s00394_009_0004_3
crossref_primary_10_1080_01635580903407213
crossref_primary_10_1007_s00217_020_03586_w
crossref_primary_10_1080_09540100802483608
crossref_primary_10_5812_ipmn_117170
crossref_primary_10_1111_jfbc_13369
crossref_primary_10_1016_j_ejphar_2014_12_009
crossref_primary_10_3109_08830185_2011_642909
crossref_primary_10_1089_jmf_2020_4712
crossref_primary_10_1016_j_tifs_2021_02_075
crossref_primary_10_3109_10837450_2012_696268
crossref_primary_10_1016_j_fct_2008_10_029
crossref_primary_10_1111_ijcp_12993
crossref_primary_10_1039_D1BM00118C
crossref_primary_10_1016_j_trsl_2012_10_008
crossref_primary_10_1016_j_jnutbio_2022_109101
crossref_primary_10_3390_antiox12101886
crossref_primary_10_1002_ibd_21843
crossref_primary_10_1007_s11101_023_09866_z
crossref_primary_10_1371_journal_pone_0019881
crossref_primary_10_1038_s41598_024_52309_8
crossref_primary_10_1002_mnfr_201100374
crossref_primary_10_1016_j_gastrohep_2009_09_006
crossref_primary_10_1155_2014_139873
Cites_doi 10.1016/j.intimp.2003.07.002
10.1136/gut.52.12.1714
10.1182/blood-2002-11-3550
10.1016/S0304-3835(03)00157-5
10.1016/S0016-5085(89)80016-2
10.1002/hep.510270512
10.1016/j.mrfmmm.2004.05.018
10.1016/S0027-5107(02)00330-5
10.1002/mnfr.200500022
10.1016/0016-5085(90)90280-E
10.1021/np0498410
10.1038/nature01960
10.1016/j.bcp.2003.12.024
10.2174/1568011033353443
10.1023/A:1012860509440
10.1016/S0014-2999(01)01410-8
10.1023/A:1026651408998
10.1016/S0006-2952(01)00775-4
10.1007/s00384-004-0585-5
10.1016/0076-6879(90)86172-R
10.1074/jbc.M002577200
10.1016/S0140-6736(02)11395-X
10.1007/BF01954148
10.1042/bj3180603
10.1016/S0006-2952(99)00380-9
10.1016/S0016-5085(89)80079-4
10.1016/j.ejphar.2003.09.033
10.1080/003655202320621436
10.3748/wjg.v9.i3.408
10.1007/s00011-004-1266-0
10.1055/s-2004-818940
10.1207/S15327914NC4402_12
10.1016/S0006-2952(97)00544-3
10.1111/j.1572-0241.2003.08703.x
10.1016/S0016-5085(98)70259-8
10.1053/j.gastro.2003.08.027
10.1016/S0014-2999(02)01494-2
10.1038/sj.emboj.7600244
10.1152/ajpgi.2000.279.1.G238
10.1021/jo0497860
10.1096/fj.04-3582fje
10.1152/ajpcell.00351.2003
10.1016/S0014-2999(02)02949-7
10.1038/9550
10.1016/j.clnu.2005.02.009
10.1016/j.intimp.2004.08.008
10.1097/00054725-200409000-00010
10.1016/S0008-6363(00)00102-4
10.1038/sj.bjp.0705688
10.1097/00042737-200207000-00008
ContentType Journal Article
Copyright 2006 British Pharmacological Society
2006 INIST-CNRS
Copyright Nature Publishing Group Apr 2006
Copyright 2006, Nature Publishing Group 2006 Nature Publishing Group
Copyright_xml – notice: 2006 British Pharmacological Society
– notice: 2006 INIST-CNRS
– notice: Copyright Nature Publishing Group Apr 2006
– notice: Copyright 2006, Nature Publishing Group 2006 Nature Publishing Group
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7QP
7RV
7TK
7X7
7XB
88E
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
NAPCQ
PQEST
PQQKQ
PQUKI
PRINS
5PM
DOI 10.1038/sj.bjp.0706469
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
ProQuest Nursing & Allied Health Database
Neurosciences Abstracts
Health & Medical Complete (ProQuest Database)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
ProQuest Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection (Proquest) (PQ_SDU_P3)
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Biological Science Database
Nursing & Allied Health Premium
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest Central (Alumni)
DatabaseTitleList ProQuest Central Student
CrossRef
MEDLINE


Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1476-5381
EndPage 885
ExternalDocumentID 1041872411
10_1038_sj_bjp_0706469
16474422
17731715
BPH2639
Genre article
Journal Article
GroupedDBID ---
.3N
.55
.GJ
05W
0R~
1OC
23N
24P
2WC
31~
33P
36B
3O-
3SF
3V.
4.4
52U
52V
53G
5GY
6J9
7RV
7X7
8-0
8-1
88E
8AO
8FE
8FH
8FI
8FJ
8R4
8R5
8UM
A00
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCUV
ABDBF
ABPVW
ABQWH
ABUWG
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFKRA
AFPWT
AFRAH
AFZJQ
AHBTC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
AOIJS
ATUGU
AZBYB
AZVAB
B0M
BAFTC
BAWUL
BBNVY
BENPR
BFHJK
BHBCM
BHPHI
BKEYQ
BMXJE
BPHCQ
BRXPI
BVXVI
C45
CAG
CCPQU
COF
CS3
DCZOG
DIK
DRFUL
DRMAN
DRSTM
DU5
E3Z
EAD
EAP
EAS
EBC
EBD
EBS
ECV
EJD
EMB
EMK
EMOBN
ENC
ESX
EX3
F5P
FUBAC
FYUFA
G-S
GODZA
GX1
H.X
HCIFZ
HGLYW
HMCUK
HYE
HZ~
J5H
KBYEO
LATKE
LEEKS
LH4
LITHE
LK8
LOXES
LSO
LUTES
LW6
LYRES
M1P
M7P
MEWTI
MK0
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
MY~
N9A
NAPCQ
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P4E
PQQKQ
PROAC
PSQYO
Q.N
Q2X
QB0
RIG
ROL
RPM
RWI
SJN
SUPJJ
SV3
TEORI
TR2
TUS
UKHRP
UPT
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WVDHM
WXSBR
X7M
XV2
Y6R
YHG
ZGI
ZXP
ZZTAW
~8M
~S-
08R
AAJUZ
AAPBV
AAUGY
AAVGM
ABCVL
ABHUG
ABPTK
ABWRO
ACXME
ADAWD
ADDAD
AFVGU
AGJLS
IQODW
ZA5
CGR
CUY
CVF
ECM
EIF
NPM
AAMNL
AAYXX
CITATION
7QP
7TK
7XB
8FK
AZQEC
DWQXO
GNUQQ
K9.
PQEST
PQUKI
PRINS
5PM
ID FETCH-LOGICAL-c5559-b7464f8bb3e22ebdfc857e6024ddbdbf557968b2b42fa778776d914834d57b1c3
IEDL.DBID RPM
ISSN 0007-1188
IngestDate Tue Sep 17 21:07:34 EDT 2024
Thu Oct 10 16:06:09 EDT 2024
Thu Nov 21 20:55:53 EST 2024
Sat Sep 28 07:46:54 EDT 2024
Sun Oct 22 16:07:51 EDT 2023
Sat Aug 24 01:03:04 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Wine
nuclear transcription factor NF-kappa B (NF-KB)
apoptosis
Inflammation
prostaglandin (PG)
Antioxidant
Stilbene derivatives
Chronic
Phytoalexin
Resveratrol
Digestive diseases
Intestinal disease
Models
Colitis
cyclooxygenase (COX)
trinitrobenzenesulphonic acid (TNBS)
neutrophils
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5559-b7464f8bb3e22ebdfc857e6024ddbdbf557968b2b42fa778776d914834d57b1c3
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0706469
PMID 16474422
PQID 217197808
PQPubID 42104
PageCount 13
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_1760707
proquest_journals_217197808
crossref_primary_10_1038_sj_bjp_0706469
pubmed_primary_16474422
pascalfrancis_primary_17731715
wiley_primary_10_1038_sj_bjp_0706469_BPH2639
PublicationCentury 2000
PublicationDate April 2006
PublicationDateYYYYMMDD 2006-04-01
PublicationDate_xml – month: 04
  year: 2006
  text: April 2006
PublicationDecade 2000
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: Basingstoke
– name: England
– name: London
PublicationTitle British journal of pharmacology
PublicationTitleAlternate Br J Pharmacol
PublicationYear 2006
Publisher Blackwell Publishing Ltd
Nature Publishing
Nature Publishing Group
Publisher_xml – name: Blackwell Publishing Ltd
– name: Nature Publishing
– name: Nature Publishing Group
References 2002; 14
2004; 286
1990; 98
2000; 47
2004; 69
2004; 25
2004; 67
2004; 23
2003; 195
2002; 236
1999; 44
1998; 115
1983; 15
2003; 52
1990; 186
2003; 98
2001; 42
2005; 24
2001; 297
2003b; 460
2004; 70
2000; 59
2002; 44
2003; 9
2003; 481
2003; 3
2000; 60
2003; 125
1998; 55
1998; 27
2003; 523–524
2003a; 3
2000; 279
2004; 141
2002; 2
2002; 3
2000; 275
2005; 49
1999; 5
2001; 25
2001; 62
2003; 33
2004; 10
1989; 96
2004; 53
1996; 318
2005; 19
2004; 555
2003; 425
2004; 19
2005; 5
2005; 51
2003; 28
2003; 102
15837718 - FASEB J. 2005 Jul;19(9):1193-5
12169985 - Eur J Gastroenterol Hepatol. 2002 Jul;14(7):757-65
15095144 - Planta Med. 2004 Apr;70(4):305-9
10371510 - Nat Med. 1999 Jun;5(6):698-701
15589480 - Int Immunopharmacol. 2005 Jan;5(1):185-93
6192115 - Histochem J. 1983 Jun;15(6):571-82
14724828 - Gastroenterology. 2003 Dec;125(6):1750-61
11356911 - J Pharmacol Exp Ther. 2001 Jun;297(3):915-25
15896420 - Clin Nutr. 2005 Jun;24(3):339-52
10963727 - Cardiovasc Res. 2000 Aug 18;47(3):549-55
15001427 - Am J Physiol Cell Physiol. 2004 Apr;286(4):C931-9
15013856 - Biochem Pharmacol. 2004 Apr 1;67(7):1399-410
9586953 - Biochem Pharmacol. 1998 Mar 15;55(6):811-6
12817628 - Ann Clin Lab Sci. 2003 Spring;33(2):226-31
2105254 - Gastroenterology. 1990 Mar;98(3):615-25
15015312 - Zhongguo Zhong Yao Za Zhi. 2003 Mar;28(3):246-9
14636824 - Int Immunopharmacol. 2003 Dec;3(13-14):1731-41
15028639 - Br J Pharmacol. 2004 Mar;141(6):997-1005
15303463 - Trop Gastroenterol. 2004 Jan-Mar;25(1):9-14
12020690 - Eur J Pharmacol. 2002 May 3;442(1-2):125-35
15152190 - EMBO J. 2004 Jun 16;23(12):2369-80
11705464 - Biochem Pharmacol. 2001 Nov 1;62(9):1299-308
12559383 - Eur J Pharmacol. 2003 Jan 24;460(2-3):209-18
15990703 - Minerva Gastroenterol Dietol. 2005 Jun;51(2):127-45
12689943 - Blood. 2003 Aug 1;102(3):987-95
14633948 - Gut. 2003 Dec;52(12):1714-20
10718345 - Biochem Pharmacol. 2000 Apr 1;59(7):865-70
12408502 - Scand J Gastroenterol Suppl. 2002;(236):37-41
11716848 - Eur J Pharmacol. 2001 Nov 9;431(1):103-10
12939617 - Nature. 2003 Sep 11;425(6954):191-6
15832402 - Mol Nutr Food Res. 2005 May;49(5):405-30
10898767 - Am J Physiol Gastrointest Liver Physiol. 2000 Jul;279(1):G238-44
14642796 - Eur J Pharmacol. 2003 Nov 28;481(2-3):281-91
15472516 - Inflamm Bowel Dis. 2004 Sep;10(5):564-72
10630507 - Dig Dis Sci. 1999 Dec;44(12):2523-9
15568761 - J Nat Prod. 2004 Nov;67(11):1777-82
10934192 - J Biol Chem. 2000 Oct 20;275(42):32681-7
14638336 - Am J Gastroenterol. 2003 Nov;98(11):2372-82
15471458 - J Org Chem. 2004 Oct 15;69(21):7101-7
12767528 - Cancer Lett. 2003 Jun 10;195(2):193-9
2172726 - Methods Enzymol. 1990;186:729-42
12628512 - Mutat Res. 2003 Feb-Mar;523-524:145-50
9581680 - Hepatology. 1998 May;27(5):1265-74
9753490 - Gastroenterology. 1998 Oct;115(4):874-82
12424006 - Lancet. 2002 Nov 2;360(9343):1410-8
2539306 - Gastroenterology. 1989 May;96(5 Pt 1):1290-300
10910059 - Cancer Res. 2000 Jul 1;60(13):3477-83
12632486 - World J Gastroenterol. 2003 Mar;9(3):408-11
12734068 - Nutr Cancer. 2002;44(2):193-201
15083321 - Int J Colorectal Dis. 2004 Sep;19(5):451-60
12678904 - Curr Med Chem Anticancer Agents. 2003 Mar;3(2):77-93
15476850 - Mutat Res. 2004 Nov 2;555(1-2):33-51
11820457 - Inflammation. 2001 Oct;25(5):301-10
15241569 - Inflamm Res. 2004 Jul;53(7):329-36
8809053 - Biochem J. 1996 Sep 1;318 ( Pt 2):603-8
2914642 - Gastroenterology. 1989 Mar;96(3):795-803
e_1_2_6_51_1
e_1_2_6_53_1
e_1_2_6_32_1
e_1_2_6_30_1
YUE G. (e_1_2_6_55_1) 2001; 297
e_1_2_6_19_1
e_1_2_6_13_1
e_1_2_6_11_1
e_1_2_6_34_1
e_1_2_6_17_1
e_1_2_6_15_1
e_1_2_6_57_1
e_1_2_6_43_1
e_1_2_6_20_1
e_1_2_6_41_1
e_1_2_6_9_1
e_1_2_6_5_1
e_1_2_6_7_1
e_1_2_6_24_1
e_1_2_6_49_1
e_1_2_6_3_1
e_1_2_6_22_1
e_1_2_6_28_1
e_1_2_6_45_1
SCHMIDT C. (e_1_2_6_46_1) 2005; 51
e_1_2_6_26_1
e_1_2_6_47_1
KURTOVIC J. (e_1_2_6_36_1) 2004; 25
e_1_2_6_52_1
e_1_2_6_54_1
e_1_2_6_10_1
e_1_2_6_50_1
LIU L. (e_1_2_6_38_1) 2003; 28
e_1_2_6_35_1
e_1_2_6_12_1
e_1_2_6_33_1
HOLMES‐MCNARY M. (e_1_2_6_31_1) 2000; 60
e_1_2_6_18_1
e_1_2_6_39_1
e_1_2_6_56_1
e_1_2_6_16_1
e_1_2_6_37_1
e_1_2_6_42_1
BOSCOLO P. (e_1_2_6_14_1) 2003; 33
e_1_2_6_21_1
e_1_2_6_40_1
e_1_2_6_8_1
e_1_2_6_4_1
e_1_2_6_6_1
e_1_2_6_25_1
e_1_2_6_48_1
e_1_2_6_23_1
e_1_2_6_2_1
e_1_2_6_29_1
e_1_2_6_44_1
e_1_2_6_27_1
References_xml – volume: 10
  start-page: 564
  year: 2004
  end-page: 572
  article-title: Catalposide, a compound isolated from catalpa ovata, attenuates induction of intestinal epithelial proinflammatory gene expression and reduces the severity of trinitrobenzene sulfonic acid‐induced colitis in mice
  publication-title: Inflamm. Bowel Dis.
– volume: 44
  start-page: 193
  year: 2002
  end-page: 201
  article-title: Resveratrol induces downregulation in survivin expression and apoptosis in HTLV‐1‐infected cell lines: a prospective agent for adult T cell leukemia chemotherapy
  publication-title: Nutr. Cancer
– volume: 44
  start-page: 2523
  year: 1999
  end-page: 2529
  article-title: Experimental colitis induced by trinitrobenzenesulphonic acid. An ultrastructural and histochemical study
  publication-title: Digest. Dis. Sci.
– volume: 62
  start-page: 1299
  year: 2001
  end-page: 1308
  article-title: Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell‐mediated cytotoxicity, and cytokine production
  publication-title: Biochem. Pharmacol.
– volume: 141
  start-page: 997
  year: 2004
  end-page: 1005
  article-title: Neuroprotective effects of resveratrol against beta‐amyloid‐induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C
  publication-title: Br. J. Pharmacol.
– volume: 3
  start-page: 125
  year: 2002
  end-page: 135
  article-title: Chronic gastric ulcer healing in rats subjected to selective and non‐selective cyclooxygenase‐2 inhibitors
  publication-title: Eur. J. Pharmacol.
– volume: 5
  start-page: 698
  year: 1999
  end-page: 701
  article-title: Inducible cyclooxygenase may have anti‐inflammatory properties
  publication-title: Nat. Med.
– volume: 3
  start-page: 1731
  year: 2003a
  end-page: 1741
  article-title: A new flavonoid derivative, dosmalfate, attenuates the development of dextran sulphate sodium‐induced colitis in mice
  publication-title: Int. Immunopharmacol.
– volume: 24
  start-page: 339
  year: 2005
  end-page: 352
  article-title: Aetiology of inflammatory bowel disease (IBD): role of intestinal microbiota and gut‐associated lymphoid tissue immune response
  publication-title: Clin. Nutr.
– volume: 52
  start-page: 1714
  year: 2003
  end-page: 1720
  article-title: Cyclooxygenase 2 mediates post‐inflammatory colonic secretory and barrier dysfunction
  publication-title: Gut
– volume: 15
  start-page: 571
  year: 1983
  end-page: 582
  article-title: Mucosal mast cells of the rat intestine: a re‐evaluation of fixation and staining properties, with special reference to protein blocking and solubility of the granular glycosaminoglycan
  publication-title: Histochem J.
– volume: 55
  start-page: 811
  year: 1998
  end-page: 816
  article-title: Interaction of transresveratrol with plasma lipoproteins
  publication-title: Biochem. Pharmacol.
– volume: 98
  start-page: 615
  year: 1990
  end-page: 625
  article-title: Misoprostol provides a colonic mucosal protective effect during acetic acid‐induced colitis in rats
  publication-title: Gastroenterology
– volume: 195
  start-page: 193
  year: 2003
  end-page: 199
  article-title: Enhanced MTT‐reducing activity under growth inhibition by resveratrol in CEM‐C7H2 lymphocytic leukemia cells
  publication-title: Cancer Lett.
– volume: 67
  start-page: 1777
  year: 2004
  end-page: 1782
  article-title: Mechanism‐based inactivation of COX‐1 by red wine ‐hydroquinones: a structure–activity relationship study
  publication-title: J. Nat. Prod.
– volume: 25
  start-page: 9
  year: 2004
  end-page: 14
  article-title: Recent advances in biological therapy for inflammatory bowel disease
  publication-title: Trop. Gastroenterol.
– volume: 51
  start-page: 127
  year: 2005
  end-page: 145
  article-title: Etiology and pathogenesis of inflammatory bowel disease
  publication-title: Minerva Gastroenterol. Dietol.
– volume: 318
  start-page: 603
  year: 1996
  end-page: 608
  article-title: Changes associate with aging and replicative senescence in the regulation of transcription factor nuclear factor‐ B
  publication-title: Biochem. J.
– volume: 14
  start-page: 757
  year: 2002
  end-page: 765
  article-title: Role of mucins in inflammatory bowel disease: important lessons from experimental models
  publication-title: Eur. J. Gastroenterol. Hepatol.
– volume: 60
  start-page: 3477
  year: 2000
  end-page: 3483
  article-title: Chemopreventive properties of ‐resveratrol are associated with inhibition of activation of the IkappaB kinase
  publication-title: Cancer Res.
– volume: 19
  start-page: 1193
  year: 2005
  end-page: 1195
  article-title: Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease
  publication-title: FASEB J.
– volume: 460
  start-page: 209
  year: 2003b
  end-page: 218
  article-title: Effects of dosmalfate, a new cytoprotective agent, on acute and chronic trinitrobenzene sulphonic acid‐induced colitis in rats
  publication-title: Eur. J. Pharmacol.
– volume: 5
  start-page: 185
  year: 2005
  end-page: 193
  article-title: Resveratrol inhibits nitric oxide and TNF‐alpha production by lipopolysaccharide‐activated microglia
  publication-title: Int. Immunopharmacol.
– volume: 555
  start-page: 33
  year: 2004
  end-page: 51
  article-title: Targeting signal transduction pathways by chemopreventive agents
  publication-title: Mutat. Res.
– volume: 286
  start-page: C931
  year: 2004
  end-page: C939
  article-title: CYP450 dietary inhibitors attenuate TNF‐alpha‐stimulated endothelial molecule expression and leukocyte adhesion
  publication-title: Am. J. Physiol. Cell Physiol.
– volume: 481
  start-page: 281
  year: 2003
  end-page: 291
  article-title: The cyclo‐oxygenase‐2 inhibitor, rofecoxib, attenuates mucosal damage due to colitis induced by trinitrobenzene sulphonic acid in rats
  publication-title: Eur. J. Pharmacol.
– volume: 42
  start-page: 103
  year: 2001
  end-page: 110
  article-title: Effects of tumor necrosis factor‐ synthesis inhibitors on rat trinitrobenzene sulphonic acid‐induced chronic colitis
  publication-title: Eur. J. Pharmacol.
– volume: 425
  start-page: 191
  year: 2003
  end-page: 196
  article-title: Small molecule activators of sirtuins extend lifespan
  publication-title: Nature
– volume: 27
  start-page: 1265
  year: 1998
  end-page: 1274
  article-title: Effect of antioxidants, resveratrol, quercetin, and ‐acetykcysteine, on the functions of cultural rat hepatic stellate cells and Kupffer cells
  publication-title: Hepatology
– volume: 9
  start-page: 408
  year: 2003
  end-page: 411
  article-title: Resveratrol induces apoptosis in human esophageal carcinoma cells
  publication-title: World J. Gastroenterol.
– volume: 279
  start-page: G238
  year: 2000
  end-page: G244
  article-title: Cyclooxygenase‐2‐derived prostaglandin D(2) is an early anti‐inflammatory signal in experimental colitis
  publication-title: Am. J. Physiol. Gastrointest. Liver Physiol.
– volume: 59
  start-page: 865
  year: 2000
  end-page: 870
  article-title: Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production
  publication-title: Biochem. Pharmacol.
– volume: 523–524
  start-page: 145
  year: 2003
  end-page: 150
  article-title: Molecular mechanism of the chemopreventive effect of resveratrol
  publication-title: Mutat. Res.
– volume: 69
  start-page: 7101
  year: 2004
  end-page: 7107
  article-title: Antioxidant activity of hydroxystilbene derivatives in homogeneous solution
  publication-title: J. Org. Chem.
– volume: 96
  start-page: 795
  year: 1989
  end-page: 803
  article-title: Hapten‐induced model of chronic inflammation and ulceration in the rat colon
  publication-title: Gastroenterology
– volume: 49
  start-page: 405
  year: 2005
  end-page: 430
  article-title: Resveratrol as an anti‐inflammatory and anti‐aging agent: mechanisms and clinical implications
  publication-title: Mol. Nutr. Food Res.
– volume: 19
  start-page: 451
  year: 2004
  end-page: 460
  article-title: Expression of apoptosis‐related proteins in rat with induced colitis
  publication-title: Int. J. Colorect. Dis.
– volume: 96
  start-page: 1290
  year: 1989
  end-page: 1300
  article-title: Treatment with 16,16′‐dimethyl prostaglandin E before and after induction of colitis with trinitrobenzenesulfonic acid in rats decreases inflammation
  publication-title: Gastroenterology
– volume: 33
  start-page: 226
  year: 2003
  end-page: 231
  article-title: Effects of resveratrol on lymphocyte proliferation and cytokine release
  publication-title: Ann. Clin. Lab. Sci.
– volume: 102
  start-page: 987
  year: 2003
  end-page: 995
  article-title: Resveratrol blocks interleukin‐1{beta}‐induced activation of the nuclear transcription factor NF‐{kappa}B, inhibits proliferation, causes S‐phase arrest, and induces apoptosis of acute myeloid leukaemia cells
  publication-title: Blood
– volume: 2
  start-page: 1410
  year: 2002
  end-page: 1418
  article-title: Role of peroxisome proliferator‐activated receptor gamma and retinoid X receptor heterodimer in hepatogastroenterological diseases
  publication-title: Lancet
– volume: 125
  start-page: 1750
  year: 2003
  end-page: 1761
  article-title: A murine model of chronic inflammation‐induced intestinal fibrosis down‐regulated by antisense NF‐kappa B
  publication-title: Gastroenterology
– volume: 53
  start-page: 329
  year: 2004
  end-page: 336
  article-title: Blood flow alterations in TNBS‐induced colitis: role of endothelin receptors
  publication-title: Inflamm. Res.
– volume: 47
  start-page: 549
  year: 2000
  end-page: 555
  article-title: Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes
  publication-title: Cardiovasc. Res.
– volume: 98
  start-page: 2372
  year: 2003
  end-page: 2382
  article-title: Novel approaches to treating inflammatory bowel disease: targeting alpha‐4 integrin
  publication-title: Am. J. Gastroenterol.
– volume: 25
  start-page: 301
  year: 2001
  end-page: 309
  article-title: Effects of a COX‐2 preferential agent nimesulide on TNBS‐induced acute inflammation in the gut
  publication-title: Inflammation
– volume: 23
  start-page: 2369
  year: 2004
  end-page: 2380
  article-title: Modulation of NF‐kappaB‐dependent transcription and cell survival by the SIRT1 deacetylase
  publication-title: EMBO J.
– volume: 186
  start-page: 729
  year: 1990
  end-page: 742
  article-title: Assessment of leukocyte involvement during ischemia and reperfusion of intestine
  publication-title: Methods Enzymol.
– volume: 297
  start-page: 915
  year: 2001
  end-page: 925
  article-title: Colon epithelial cell death in 2,4,6‐trinitrobenzenesulfonic acid‐induced colitis is associated with increased inducible nitric‐oxide synthase expression and peroxynitrite production
  publication-title: J. Pharmacol. Exp. Ther.
– volume: 28
  start-page: 246
  year: 2003
  end-page: 249
  article-title: Effects of tanguticum maxim polysaccharide on ulcerative colitis induced by TNBS in rats
  publication-title: Zhongguo Zhong Yao Za Zhi
– volume: 236
  start-page: 37
  issue: (Suppl)
  year: 2002
  end-page: 41
  article-title: Blockade of NF‐kappaB activation and donation of nitric oxide: new treatment options in inflammatory bowel disease
  publication-title: Scand. J. Gastroenterol.
– volume: 70
  start-page: 305
  year: 2004
  end-page: 309
  article-title: Resveratrol inhibits the release of mediators from bone marrow‐derived mouse mast cells
  publication-title: Planta Med.
– volume: 275
  start-page: 32681
  year: 2000
  end-page: 32687
  article-title: Oxidized low density lipoprotein inhibits interleukin‐12 production in lipopolysaccharide‐activated mouse macrophages direct interactions between peroxisome proliferator‐activated receptor‐ and nuclear factor‐ B
  publication-title: J. Biol. Chem.
– volume: 67
  start-page: 1399
  year: 2004
  end-page: 1410
  article-title: Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats
  publication-title: Biochem. Pharmacol.
– volume: 3
  start-page: 77
  year: 2003
  end-page: 93
  article-title: Resveratrol and cancer: chemoprevention, apoptosis, and chemo‐immunosensitizing activities
  publication-title: Curr. Med. Chem. Anti-Cancer Agents
– volume: 115
  start-page: 874
  year: 1998
  end-page: 882
  article-title: Prostaglandins prevent decreased epithelial cell proliferation associated with dextran sodium sulfate injury in mice
  publication-title: Gastroenterology
– ident: e_1_2_6_51_1
  doi: 10.1016/j.intimp.2003.07.002
– ident: e_1_2_6_56_1
  doi: 10.1136/gut.52.12.1714
– ident: e_1_2_6_23_1
  doi: 10.1182/blood-2002-11-3550
– ident: e_1_2_6_10_1
  doi: 10.1016/S0304-3835(03)00157-5
– ident: e_1_2_6_4_1
  doi: 10.1016/S0016-5085(89)80016-2
– ident: e_1_2_6_43_1
  doi: 10.1002/hep.510270512
– ident: e_1_2_6_13_1
  doi: 10.1016/j.mrfmmm.2004.05.018
– ident: e_1_2_6_20_1
  doi: 10.1016/S0027-5107(02)00330-5
– ident: e_1_2_6_3_1
  doi: 10.1002/mnfr.200500022
– ident: e_1_2_6_24_1
  doi: 10.1016/0016-5085(90)90280-E
– volume: 25
  start-page: 9
  year: 2004
  ident: e_1_2_6_36_1
  article-title: Recent advances in biological therapy for inflammatory bowel disease
  publication-title: Trop. Gastroenterol.
  contributor:
    fullname: KURTOVIC J.
– ident: e_1_2_6_47_1
  doi: 10.1021/np0498410
– ident: e_1_2_6_32_1
  doi: 10.1038/nature01960
– ident: e_1_2_6_40_1
  doi: 10.1016/j.bcp.2003.12.024
– volume: 33
  start-page: 226
  year: 2003
  ident: e_1_2_6_14_1
  article-title: Effects of resveratrol on lymphocyte proliferation and cytokine release
  publication-title: Ann. Clin. Lab. Sci.
  contributor:
    fullname: BOSCOLO P.
– ident: e_1_2_6_15_1
  doi: 10.2174/1568011033353443
– ident: e_1_2_6_34_1
  doi: 10.1023/A:1012860509440
– ident: e_1_2_6_12_1
  doi: 10.1016/S0014-2999(01)01410-8
– ident: e_1_2_6_50_1
  doi: 10.1023/A:1026651408998
– volume: 297
  start-page: 915
  year: 2001
  ident: e_1_2_6_55_1
  article-title: Colon epithelial cell death in 2,4,6‐trinitrobenzenesulfonic acid‐induced colitis is associated with increased inducible nitric‐oxide synthase expression and peroxynitrite production
  publication-title: J. Pharmacol. Exp. Ther.
  contributor:
    fullname: YUE G.
– ident: e_1_2_6_25_1
  doi: 10.1016/S0006-2952(01)00775-4
– volume: 28
  start-page: 246
  year: 2003
  ident: e_1_2_6_38_1
  article-title: Effects of tanguticum maxim polysaccharide on ulcerative colitis induced by TNBS in rats
  publication-title: Zhongguo Zhong Yao Za Zhi
  contributor:
    fullname: LIU L.
– ident: e_1_2_6_17_1
  doi: 10.1007/s00384-004-0585-5
– ident: e_1_2_6_27_1
  doi: 10.1016/0076-6879(90)86172-R
– volume: 60
  start-page: 3477
  year: 2000
  ident: e_1_2_6_31_1
  article-title: Chemopreventive properties of trans‐resveratrol are associated with inhibition of activation of the IkappaB kinase
  publication-title: Cancer Res.
  contributor:
    fullname: HOLMES‐MCNARY M.
– ident: e_1_2_6_16_1
  doi: 10.1074/jbc.M002577200
– ident: e_1_2_6_21_1
  doi: 10.1016/S0140-6736(02)11395-X
– ident: e_1_2_6_53_1
  doi: 10.1007/BF01954148
– ident: e_1_2_6_30_1
  doi: 10.1042/bj3180603
– ident: e_1_2_6_41_1
  doi: 10.1016/S0006-2952(99)00380-9
– ident: e_1_2_6_42_1
  doi: 10.1016/S0016-5085(89)80079-4
– ident: e_1_2_6_39_1
  doi: 10.1016/j.ejphar.2003.09.033
– ident: e_1_2_6_19_1
  doi: 10.1080/003655202320621436
– ident: e_1_2_6_57_1
  doi: 10.3748/wjg.v9.i3.408
– ident: e_1_2_6_18_1
  doi: 10.1007/s00011-004-1266-0
– ident: e_1_2_6_7_1
  doi: 10.1055/s-2004-818940
– volume: 51
  start-page: 127
  year: 2005
  ident: e_1_2_6_46_1
  article-title: Etiology and pathogenesis of inflammatory bowel disease
  publication-title: Minerva Gastroenterol. Dietol.
  contributor:
    fullname: SCHMIDT C.
– ident: e_1_2_6_29_1
  doi: 10.1207/S15327914NC4402_12
– ident: e_1_2_6_8_1
  doi: 10.1016/S0006-2952(97)00544-3
– ident: e_1_2_6_44_1
  doi: 10.1111/j.1572-0241.2003.08703.x
– ident: e_1_2_6_48_1
  doi: 10.1016/S0016-5085(98)70259-8
– ident: e_1_2_6_37_1
  doi: 10.1053/j.gastro.2003.08.027
– ident: e_1_2_6_9_1
  doi: 10.1016/S0014-2999(02)01494-2
– ident: e_1_2_6_54_1
  doi: 10.1038/sj.emboj.7600244
– ident: e_1_2_6_2_1
  doi: 10.1152/ajpgi.2000.279.1.G238
– ident: e_1_2_6_5_1
  doi: 10.1021/jo0497860
– ident: e_1_2_6_6_1
  doi: 10.1096/fj.04-3582fje
– ident: e_1_2_6_45_1
  doi: 10.1152/ajpcell.00351.2003
– ident: e_1_2_6_52_1
  doi: 10.1016/S0014-2999(02)02949-7
– ident: e_1_2_6_26_1
  doi: 10.1038/9550
– ident: e_1_2_6_49_1
  doi: 10.1016/j.clnu.2005.02.009
– ident: e_1_2_6_11_1
  doi: 10.1016/j.intimp.2004.08.008
– ident: e_1_2_6_35_1
  doi: 10.1097/00054725-200409000-00010
– ident: e_1_2_6_33_1
  doi: 10.1016/S0008-6363(00)00102-4
– ident: e_1_2_6_28_1
  doi: 10.1038/sj.bjp.0705688
– ident: e_1_2_6_22_1
  doi: 10.1097/00042737-200207000-00008
SSID ssj0014775
Score 2.3634386
Snippet Neutrophil infiltration, proinflammatory cytokines, eicosanoid generation and oxidative stress have been implicated in colitis. Resveratrol is a polyphenolic...
SourceID pubmedcentral
proquest
crossref
pubmed
pascalfrancis
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 873
SubjectTerms Animals
Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
apoptosis
Biological and medical sciences
Colitis - chemically induced
Colitis - drug therapy
Colitis - metabolism
Colitis - pathology
Colon - drug effects
Colon - metabolism
Colon - pathology
cyclooxygenase (COX)
Cyclooxygenase 1 - metabolism
Cyclooxygenase 2 - metabolism
Dinoprostone - metabolism
Gene Expression Regulation
Inflammation - drug therapy
Male
Medical sciences
Membrane Proteins - metabolism
neutrophils
NF-kappa B - metabolism
nuclear transcription factor NF‐kappa B (NF‐κB)
Peroxidase - metabolism
Pharmacology. Drug treatments
prostaglandin (PG)
Prostaglandin D2 - metabolism
Rats
Rats, Wistar
Resveratrol
Sesquiterpenes
Stilbenes - chemistry
Stilbenes - therapeutic use
Terpenes - chemistry
Terpenes - therapeutic use
Trinitrobenzenesulfonic Acid - toxicity
trinitrobenzenesulphonic acid (TNBS)
Tumor Necrosis Factor-alpha - metabolism
Wine - analysis
SummonAdditionalLinks – databaseName: Wiley-Blackwell
  dbid: 33P
  link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5BT0iINzQUqjmgcklK4zi2OfJo1RNaiSJxi-zYFqyqZNW0Rfsf-NGM7Wy2EUgIcYoij6XE_saesWe-AXjFXel1xWRRc6sKLrwrDLd1wZSVjvlQ2CoWsf0sP31VH48DTc6UxZ_4IaYDt6AZcb0OCq7NMKaJh8D1YXlolqtDgqwgF48WYXIVYg5HtZiuEbiUqYRBYEIsldqwNlbqzbz7bFe6u9IDDZBPlS3-ZHr-HkF507KNW9PJ_f__qQdwbzRL8V3C0UO45bpHcLBIvNbrHM-2aVpDjge42DJerx_DT2rGMTIEe4_kwl8HsuaL_jxHjTSTl70OzJsdWkL8tbMY0lpIzuKPEHefY99hm3h6kTBPME0plfRiCXyWnqg7vFmP4Hw9NbYxiG_AWNbnCXw5OT77cFqMZR6KtiZ_pjCSC-6VMZVjzBnrW1VLJ8h4sNZY4-uQLqsMM5x5LWmBkcK-LcMhqK2lKdvqKex0fed2AY80madW6ZBty1stNBdtKaRoNdk1vjrK4PVmmptVYvNo4i18pZph2dDQN-PQZ7A_Q8FWXEoyuco6g70NLJpR7YeG_LsyUDqpDJ4lgGz7CS45ZywDOYPOJBB4vuct3fdvke-7lCKQMmWQR-j85cub94tTRnbn838T34M76XQpBCW9gJ3Liyv3Em4P9mo_6tQvbsIo-A
  priority: 102
  providerName: Wiley-Blackwell
Title The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model
URI https://onlinelibrary.wiley.com/doi/abs/10.1038%2Fsj.bjp.0706469
https://www.ncbi.nlm.nih.gov/pubmed/16474422
https://www.proquest.com/docview/217197808
https://pubmed.ncbi.nlm.nih.gov/PMC1760707
Volume 147
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB66ORVK6btO2kWHkl7s3ViWJfXY5kFKaTE0hd6MnjTLxl7iJGX_Q390R7KdzdJCoRcbIwkbzyfrG3nmG4A3zOVeFVRkJbMyY9y7TDNbZlRa4agPha1iEduv4st3eXQcZHLKMRcmBu0bfT5rlhez5vxHjK1cXZj5GCc2rz4f5oIHlZr5BCbIDUcXffh1wIToyxYE9cNcylGpsZDzbjHTi9UMx3L0CoNeKGeCMUq3FqUHK9Xh-_F9YYu_Mc8_AyjvEtu4Mp08gocDpSTv-0d_DPdc8wT2q16Tep2Ss02KVZeSfVJt1KrXT-EXNpMhqoO0nqD7fROEli_bZUoUQStctSqoZjbEIlpvnCUhJQX7WfIzxMynpG2I6TV2CeIVIdanQ-KFReBYPBPVkLu1BJbr20YTA_A6EkvyPINvJ8dnh6fZUKIhMyX6IpkWjDMvtS4cpU5bb2QpHMeF31pttS9DqqvUVDPqlcCPg-D2XR42MG0pdG6K57DTtI17CeRAIbW0UoVMWWYUV4ybnAtuFHISXxwk8Ha0Ub3qlTjq-Ae9kHW3qNGw9WDYBKZbJtx0FwLpUl4msDfatB6mbFejb5YHOSaZwIveuptxA0wSEFt2v-0QNLq3WxC6Uat7gGoCaUTIP568_lCdUuSMu_99oz24328ShdiiV7BzdXntXsOks9dTmBRFhcejj5-mccr8BoHnG6Y
link.rule.ids 230,315,729,782,786,887,1408,27933,27934,46064,46488,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwEB3RcgCp4psSCmUOqFw2pXEc2xwLtFpEqVZikbhFdmwLVlWyatqi_Q_8aMZxdrcRSAiJUxR5LCX2G3s8nnkD8JK7zOucybTgVqVceJcabouUKSsd86GwVVfE9rM8_areHwWanMNlLkzkh1g53IJmdOt1UPDgkO7zxEPkejvbN7P5PmFW0BlvA25yQWgMWRz5ZHWRwKWMRQwCF2Km1JK3MVevh_0H-9LWXLc0RD7WtviT8fl7DOV127bbnI7v_offugd3essUDyOU7sMNVz-AvUmktl6McLrO1GpHuIeTNen14iH8pGbsg0Ow8Uin-KvA13zenI1QI03mRaMD-WaNlkB_5SyGzBaSs_gjhN6PsKmxilS9SLAnpMasSnqxhD9LT9Q1Xi9JcLZYNVZdHF-LXWWfR_Dl-Gj6bpz2lR7SqqAjTWokzZ1XxuSOMWesr1QhnSD7wVpjjS9CxqwyzHDmtaQ1Rgr7Jgt-UFtIk1X5Y9ism9o9ATzQZKFapUPCLa-00FxUmZCi0mTa-PwggVfLeS7nkdCj7C7ic1W2s5KGvuyHPoHdAQzW4lKS1ZUVCewscVH2mt-WdMTLAquTSmA7ImTdT3DJOWMJyAF2VgKB6nvYUn__1lF-Z1IEXqYERh12_vLl5dvJmJHp-fTfxF_ArfH000l58uH04w7cjs6mEKP0DDYvzi_dc9ho7eVup2C_AAHpLSA
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fa9UwFD64CSIMfzvrdOZB5ks71zRN4qO6XSbKKDjBt5I0CXoZ7WXdJvd_8I_2JOntXVEQ8amUnECbfEm-JOd8B-Als7lTBRVZyYzMGHc208yUGZVGWOp8YquQxPazOPkqD4-8TM4YxR_1IcYDNz8ywnztB_jCuCFM3Duu9_N9PV_sI2Q5bvE24CZDLu7V84uiGu8RmBAxh4GXQsylXMk2FvL1tP5kWdpaqB5byMXUFn_inr-7UF6ntmFtmt39_7-6B3cGXkreRiDdhxu2fQB7VRS2XqbkdB2n1adkj1RryevlQ_iJxWRwDSGdI7iHv_JqzefdWUoUwa686JSX3myJQchfWUN8XAvaGfLDO96npGtJE4V6CYIecRpjKvHFIPoMPolqyfWEBGfLsbAJXnw9CXl9HsGX2dHp--NsyPOQNSVuaDItGGdOal1YSq02rpGlsBzZgzHaaFf6eFmpqWbUKYEzjODmTe5PQU0pdN4Uj2Gz7Vr7BMiBQn5qpPLhtqxRXDHe5FzwRiGxccVBAq9W3VwvopxHHa7hC1n38xqbvh6aPoHdCQrW5kIg58rLBHZWsKiHcd_XuMHLvaaTTGA7AmRdjzPBGKUJiAl0RgMv9D0tab9_C4LfueBelSmBNEDnL19ev6uOKRLPp_9m_gJuVYez-tOHk487cDueNHkHpWeweXF-aZ_DRm8ud8Pw-gVFlSvG
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+effects+of+resveratrol%2C+a+phytoalexin+derived+from+red+wines%2C+on+chronic+inflammation+induced+in+an+experimentally+induced+colitis+model&rft.jtitle=British+journal+of+pharmacology&rft.au=Mart%C3%ADn%2C+Antonio+Ram%C3%B3n&rft.au=Villegas%2C+Isabel&rft.au=S%C3%A1nchez%E2%80%90Hidalgo%2C+Marina&rft.au=De+La+Lastra%2C+Catalina+Alarc%C3%B3n&rft.date=2006-04-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=0007-1188&rft.eissn=1476-5381&rft.volume=147&rft.issue=8&rft.spage=873&rft.epage=885&rft_id=info:doi/10.1038%2Fsj.bjp.0706469&rft.externalDBID=10.1038%252Fsj.bjp.0706469&rft.externalDocID=BPH2639
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1188&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1188&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1188&client=summon